Objective: To compare the outcomes of postpartum hemorrhage (PPH) episodes before and after the introduction of a clinical pathway known as the Severance Protocol to save postpartum bleeding through Expeditious care Delivery (SPEED). Design: This study was designed as a retrospective analysis. Setting: The study was conducted in a hospital implementing SPEED. Participants: The non-SPEED group included 74 patients with PPH who were treated before the introduction of SPEED, whereas the SPEED group included 155 patients. Methods: Differences in outcomes were compared between groups. Main Outcome Measures: Reduction in treatment duration was the primary outcome measure, whereas uterus preservation was the secondary. Results: No significant intergroup differences were observed for hemoglobin levels, hematocrit values and vital signs upon patients' emergency room arrival. The turnaround time for hemoglobin, mean duration until treatment by obstetricians and gynecologists and duration between chest radiography ordering and performance significantly differed between the two groups (SPEED, Conclusions: Clinical pathways enable prompt and efficient care for patients experiencing PPH through faster evaluation and access to red blood cell transfusion, resulting in a decrease in maternal mortality.
Introduction
Postpartum hemorrhage (PPH), which is generally defined as >500 ml of vaginal bleeding within 24 h of delivery, is a major cause of maternal morbidity and mortality worldwide [1] and is associated with ∼1.2-3% of all deliveries in developed countries [2] [3] [4] [5] . From 1995 to 2006, a rising trend was observed in the rate of obstetric hemorrhage cases in the USA [6] . Furthermore, data from Canada, Australia and Europe have shown recent increases in PPH rates [7] , whereas PPH remains a major cause of maternal mortality in Korea [8] . As intractable obstetric hemorrhage is associated with a higher risk of maternal mortality, timely patient assessment and hemodynamic stabilization via careful monitoring of blood loss amount are critical, and prompt treatment must be initiated to avoid severe maternal morbidity and mortality. In order to achieve such goals, expert medical personnel, including obstetricians, emergency medicine specialists, anesthesiologists and nurses, with abundant experience in managing PPH must be involved in patient care. However, there remains an urgent need to introduce a standardized, consistent protocol as variation in medical practice and experience level among healthcare personnel is inevitable. Therefore, the Joint Commission Sentinel Alert has recommended the introduction of protocols to address maternal morbidity and mortality due to PPH [9] . PPH, which is considered 'a bloody business', requires immediate care from different medical specialties. In addition, because it is a critical situation, PPH management in the emergency department (ED) can be chaotic, and a lack of coordination often culminates in miscommunication, redundant calls, inconsistent care, inefficient use of manpower and in-hospital time delay.
The use of computerized physician order entry (CPOE)-based stroke team approach has been shown to aid in reducing the time interval between a patient's arrival and therapy [10] . Therefore, we have established and implemented a patient safety protocol utilizing the CPOE and physician alert system to facilitate a multidisciplinary clinical pathway (CP) for PPH management. Such a system, known as the Severance Protocol to save postpartum bleeding through Expeditious care Delivery (SPEED), was developed in Severance Hospital in 2009. The purpose of this study was to determine the effectiveness of CP by comparing treatment characteristics and clinical outcomes before and after the implementation of this program.
Methods
The CPOE system specifically designed for PPH management, known as SPEED, was implemented in Severance Hospital in 2009. In the present study, we retrospectively reviewed the medical records of all patients with PPH transferred to our institution between January 2007 and March 2014. This study was approved by the institutional review board of Yonsei University Health System. Seventy-four patients with PPH who were treated before the implementation of SPEED (from January 2007 to July 2009) were included in the non-SPEED group, whereas 155 patients managed with SPEED (from August 2009 to March 2014) were in the SPEED group. Unstable vital signs were defined as systolic blood pressure of <90 mmHg or diastolic pressure of <60 mmHg, and a heart rate of >100 beats per minute on a patient's arrival at the ED.
SPEED involved the participation of the department of obstetrics and gynecology (OBGYN), ED, division of obstetric anesthesiology, department of radiology, department of laboratory medicine and department of nursing, and the blood bank (Fig. 1) . We developed a standard protocol and CP to expedite diagnosis of PPH and efficiently manage PPH in urgent situations. The multidisciplinary team approach was implemented as follows (Fig. 2) .
When our OBGYN department received a transfer request from a private clinic, patient information, including vital signs, number of intravenous (IV) lines, transfusion amount and nil per os (NPO) time, was checked by the OBGYN physician on duty and alerted to on-call senior OBGYN physicians and ED physicians. The patient was registered on our electronic medical record (EMR) system before arrival, and each department involved in SPEED was notified.
The on-duty OBGYN physician was instructed to wait for the patient at the emergency room (ER) and assess her condition upon arrival. The decision to activate SPEED was made by the OBGYN physician after patient assessment. If the patient was eligible for SPEED, the OBGYN physician clicked the SPEED check box at the upper corner of her EMR window and selected the activation icon. Once the SPEED program was activated, the patient's name was highlighted in pink color, and a text message was sent to every SPEED team member automatically. Consequently, every department involved could easily and promptly recognize this patient. At the same time, patient vital signs were evaluated, and the need for monitoring, oxygen supply, two or more IV lines or blood product transfusion was determined.
A predesigned set of orders named the 'SPEED orders' was given, and details about blood product preparation were coordinated with the blood bank. The patient's blood sample collected in a container labeled 'SPEED' was sent to a laboratory using air shooter. SPEED involved the emergency release of O-negative red blood cells (RBCs) and if time permitted, cross-matched blood products were provided as ordered. A senior OBGYN physician, an obstetric anesthesiologist and a radiologist were also notified about the patient's condition simultaneously. A pre-anesthesia screening was performed, including blood test, urine test, chest radiography and electrocardiography. We empowered priority to relevant departments to process results for a SPEED patient, and laboratory technicians sent preliminary results via text messages to the treating OBGYN physician.
The treatment plan-uterotonics only, balloon tamponade, pelvic arterial embolization (PAE) or cesarean hysterectomy-was determined based on the patient's vital signs and blood test results. The SPEED program was deactivated after the treatment plan was determined. Specifically, when the patient left the ER to undergo surgery or any procedure or be admitted to the intensive care unit, the OBGYN physician deactivated the program. Deactivation was completed by clicking the SPEED checkbox on the patient's order window and selecting the deactivation icon. Subsequently, the pink highlight on the SPEED patient's name disappeared, and a text message about deactivation was sent to every SPEED team member automatically.
We compared maternal characteristics between the SPEED and non-SPEED groups using the Mann-Whitney U-test or Fisher's exact test (categorical variables) and two-sample t-test or one-way ANOVA (continuous variables). Statistical significance was determined by P-values of <0.05, and all statistical analysis was performed using SPSS version 20.0 (SPSS Institute, Chicago, IL).
Results
In total, 229 patients with PPH were referred to our institution from private clinics during the study period. Of these, the SPEED program was activated for 155 patients. Demographic characteristics were not significantly different between the two groups, except age, delivery mode and treatment prior to transfer ( Table 1) . The most common cause of PPH was uterine atony in both groups, and there was no significant difference with regard to the etiology of PPH. Uterotonics administration was the most common treatment performed prior to transfer, and it was performed in 79.7% (59/74) and 57.4% (89/ 155) of the patients in the non-SPEED and SPEED group, respectively (P < 0.001). The percentage of patients transferred without any treatment was higher for the SPEED group (28/155, 18.1%) compared with the non-SPEED group (2/74, 2.7%). This might be because private clinics started to transfer PPH patients quickly after the SPEED program became widely known. Intrauterine tamponade with a Bakri balloon catheter was used in 13.5% (21/155) of the cases in the SPEED group, but not in any case in the non-SPEED group, mainly because Bakri balloon tamponade was only made available in Korea in 2009 (P < 0.001). There were no significant differences in vital signs, including pulse rate, blood pressure, hemoglobin level, hematocrit concentration, platelet count, prothrombin time and partial thromboplastin time at the time of arrival between the two groups ( Table 1) . The turnaround time for hemoglobin shortened from 17 to 10 min after SPEED implementation (P < 0.001) ( Table 2 ). In addition, the time interval between an OBGYN physician being notified and actual patient encounter reduced to 3 min (range, 0-25), and the duration between chest radiography ordering and performance reduced to 23 min (range, 1-86) in the SPEED group (P < 0.001). Furthermore, although transfusion with O-negative RBCs commenced within 30 min in both groups, the turnaround time for cross-matched RBC transfusion was shorter in the SPEED group (77.6 ± 58.6 min) than the non-SPEED group (103.4 ± 64.4 min) (P = 0.015). In total, 127 (81.9%) SPEED and 61 (82.4%) non-SPEED patients subsequently received blood products (Table 3 ). The frequency of O-negative RBC transfusion increased from 6 patients (9.8%) to 43 patients (33.9%) after initiation of the SPEED program.
The management strategies and outcomes after the introduction of SPEED in our institution are presented in Table 4 . First, the duration from patient arrival at the ER to the first actual treatment reduced from 86 to 76 min (P = 0.015). Second, there were significant differences between the two groups in terms of management techniques, such as uterotonics, use of Bakri balloon tamponade, PAE or cesarean hysterectomy (P = 0.022). Furthermore, the number of patients who underwent PAE reduced from 51.4% (38/74) to 47.7% (74/155), and that of hysterectomy cases from 20.3% (15/74) to 9.7% (15/155) in the SPEED group after the availability of Bakri balloon tamponade. Finally, the rates of uterus preservation were 90.1% (136/151) and 81.7% (58/71) for the SPEED and non-SPEED groups, respectively, and the rate of cesarean hysterectomy tended to decrease in the SPEED group (P = 0.043).
Discussion
It is crucial that quality of care be analyzed to enhance the level of care and implement improved medical care to benefit patients [11] [12] [13] [14] [15] . Thus, the ultimate objective of this study was to evaluate the effectiveness of a standardized protocol on PPH management. Fast and multidisciplinary approaches are essential for achieving favorable outcomes for PPH. Our results indicated that the time from patient arrival to actual diagnosis and treatment decreased after SPEED implementation, and such a reduction resulted in favorable patient outcomes.
At our institution, SPEED was introduced because delayed attention and treatment of PPH patients arriving at the ER could result in severe morbidity and mortality. Previously, at our institution, every process had to be verified in order to minimize the risk of miscommunication between departments, avoid ignorance of procedures or treatments during rapid patient assessment and ensure prompt procedure and treatment decision-making. Therefore, there was a need to improve our procedures for PPH management. In addition, we intended to prevent delay in the workflow with respect to processing of laboratory test results or preparing of blood products for transfusion owing to excessive demand from other departments. With the SPEED program, we could initiate treatment promptly and provide early intervention to reduce the amount of transfused blood products and prevent progression to lifethreatening conditions, such as disseminated intravascular coagulation. In this study, the turnaround time for cross-matched RBCs decreased in the SPEED group possibly because of a consensus to quickly process all requirements for a SPEED patient by all departments involved. The need for treatment protocols to manage PPH has been recognized worldwide, and comprehensive protocols have been introduced in many institutions [16, 17] . In the USA, multidisciplinary protocols for the effective treatment of maternal hemorrhage and training for management of obstetric hemorrhage are mandatory in the states of New York and Illinois [18] . Shields et al. [19] reported that a protocol for management of obstetric hemorrhage reduced blood product utilization and improved patient safety. More importantly, after a standard protocol was implemented, the clinical knowledge of medical staff members improved remarkably, and they were less stressed when encountering obstetric hemorrhage cases. In 2004, Rizvi F et al. [20] reported faster detection and treatment of PPH after the development of guidelines for PPH management and medical staff training.
The number of patients without any treatment prior to transfer increased in the SPEED group because these patients were sent from private clinics promptly after the SPEED system was deployed. In addition, the Bakri balloon tamponade, which presently is the only instrument specifically designed to treat PPH and was introduced in Korea in 2009, was used as one of the treatments prior to transfer in the SPEED group.
We hypothesized that the transfusion of O-negative RBCs increased in the SPEED group because the turnaround time for crossmatched RBCs was longer than that for O-negative uncross-matched RBCs. In order to avoid over usage of O-negative uncross-matched RBCs, we further clarified that up to two units of O-negative RBCs could be used in the CP. Gutierrez et al. [21] reported that massive transfusion protocol (MTP) could provide early access to blood products, including RBCs, plasma and platelets, for PPH patients, and MTP could improve outcomes of patients presenting with major obstetric hemorrhage. Our protocol also emphasized the importance of transfusion therapy for acute management of PPH. Therefore, since the SPEED protocol included O-negative blood transfusion in the early phase, the use of O-negative blood increased, and the ability to start transfusion early resulted in enhanced maternal outcome. In terms of patient management upon arrival at the ED, 11% of patients were treated with Bakri balloon tamponade for PPH. If these patients were presented before the introduction of Bakri balloon tamponade, additional treatment such as PAE might have been necessary to control bleeding. The reduced utilization of PAE aided in the decrease of procedure-related complications and medical expense. In terms of outcomes, more patients showed good recovery, and the uterus preservation rate was higher in the SPEED group. When a patient arrived at the ER and a treatment plan involving uterotonics only, Bakri balloon tamponade, PAE, cesarean hysterectomy or others was decided, we also evaluated to see whether any further treatment was necessary. Additionally, the proportion of patients who needed further treatment after the initial management at our institution was 18.1% (28/155) in the SPEED group (data not shown). Further treatments included PAE (11%, 17/155), hysterectomy (1.3%, 2/155) and others (5.8%, 9/155) such as bleeding vessel ligation, abdominal wall hematoma evacuation or methotrexate treatment for retained placenta. Among the patients who underwent PAE for further treatment, the primary treatment was uterotonics in five cases and Bakri balloon tamponade in eight. Three of these eight cases involved temporary usage of Bakri balloon tamponade after PAE was chosen as the primary treatment. Re-embolization was necessary in two cases, and two other cases needed embolization after cesarean hysterectomy was decided as the primary management.
In conclusion, our results showed that laboratory tests were performed promptly, and the time from patient arrival to first consultation with the physician decreased after SPEED was introduced. This might have resulted in the increased uterus preservation rate observed after SPEED was implemented. Development of comprehensive protocols and implementing of such protocols in the involved departments enabled the standardization of treatment for PPH and maximized the efficiency of the multidisciplinary team approach. 
